Dr Renee A Berna, MD | |
5045 Rte 130 S, Ste E, Delran, NJ 08075-9707 | |
(856) 764-2525 | |
(856) 764-6344 |
Full Name | Dr Renee A Berna |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Location | 5045 Rte 130 S, Delran, New Jersey |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124176524 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | MA068350 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Renee A Berna, MD 5045 Rte 130 S, Ste E, Delran, NJ 08075-9707 Ph: (856) 764-2525 | Dr Renee A Berna, MD 5045 Rte 130 S, Ste E, Delran, NJ 08075-9707 Ph: (856) 764-2525 |
News Archive
Survival rates for patients with lung cancer increase dramatically the earlier the disease is diagnosed, underscoring the need for effective biomarkers that can be used for detection. Now, scientists at The Wistar Institute have found a protein that circulates in the blood that appears to be more accurate at detecting non-small cell lung cancer (NSCLC) than currently available methods used for screening.
In order for medical students to ultimately provide quality patient care medical schools should turn to radiologists to help them teach physiology, one of the core disciplines of medicine, according to a study in the February issue of the Journal of the American College of Radiology (www.jacr.org). Physiology is the science of the function of living systems.
Small differences in diet - even without weight loss - can significantly affect risk for diabetes, according to research from the University of Alabama at Birmingham published online May 18, 2011, by the American Journal of Clinical Nutrition.
VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the company's new drug application (NDA) for its investigational drug, Qnexa®, for the treatment of obesity. The target date for the FDA to complete its review of the Qnexa NDA is October 28, 2010.
Cook Medical has launched a suite of salivary duct access products that offer minimally invasive options for the treatment of obstructive salivary gland disease. Minimally invasive treatment of obstructive salivary gland disease can reduce the need for invasive open surgery.
› Verified 3 days ago
Debora Anne Rausch, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 8008 Route 130 North, Suite 120, Delran, NJ 08075 Phone: 856-764-7997 Fax: 856-764-1840 | |
Sofiya Mirson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 950 S Chester Ave Ste A, Suite 10, Delran, NJ 08075 Phone: 856-764-2500 Fax: 856-764-8335 | |
Dr. Suzanne H. Shenk, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8008 Route 130 Ste 120, Delran, NJ 08075 Phone: 856-764-7997 Fax: 856-764-1840 | |
Lutsiya S Pelimskaya, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8008 Route 130 Ste 120, Delran, NJ 08075 Phone: 856-764-1840 Fax: 856-764-7997 | |
Dr. Herbert C. Conaway Jr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 26 Waters Edge Dr, Delran, NJ 08075 Phone: 609-456-0039 Fax: 888-585-0180 | |
Dr. Jeffrey Errol Epstein, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2906 Route 130 South, Suite 201, Delran, NJ 08075 Phone: 856-764-4115 Fax: 856-764-4116 |